North America dominates the Corneal Repair Materials market with a 40% value share, driven by advanced healthcare infrastructure, high adoption of premium corneal grafts, and robust R&D investments. The US leads with favorable reimbursement policies and a mature ecosystem for regenerative therapies. Europe follows with 30%, supported by stringent regulatory frameworks ensuring product quality, aging demographics with corneal disease prevalence, and cross-border collaborations in tissue engineering. Asia Pacific (18%) is the fastest-growing region, fueled by rising ophthalmic disorder incidence, government-funded healthcare expansion in China and India, and increasing partnerships between global manufacturers and local distributors. Latin America (8%) gains traction through public-private healthcare infrastructure upgrades and rising awareness of corneal disease management. Middle East & Africa (4%) shows potential via strategic investments in medical tourism and international NGO partnerships, though adoption remains constrained by economic disparities.